Agios Pharmaceuticals
AGIO
#5091
Rank
NZ$3.12 B
Marketcap
NZ$52.32
Share price
-3.10%
Change (1 day)
31.50%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: NZ$3.12 Billion

As of November 2026 Agios Pharmaceuticals has a market cap of NZ$3.12 Billion. This makes Agios Pharmaceuticals the world's 5091th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$3.12 B10.92%
2025NZ$2.82 B-16.47%
2024NZ$3.37 B71.6%
2023NZ$1.96 B-19.01%
2022NZ$2.43 B-7.02%
2021NZ$2.61 B-37.16%
2020NZ$4.15 B-14.24%
2019NZ$4.84 B21.18%
2018NZ$4.00 B1.97%
2017NZ$3.92 B55.06%
2016NZ$2.53 B-29.21%
2015NZ$3.57 B-32.6%
2014NZ$5.30 B483.39%
2013NZ$0.90 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Agios Pharmaceuticals was reported to be:

NZ$3.12 Billion
by Nasdaq info icon info icon
NZ$3.12 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$285.58 B 9,025.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$2.189 T 69,866.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$174.38 B 5,472.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
NZ$4.64 B 48.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$29.22 B 833.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$21.64 B 591.62%๐Ÿ‡บ๐Ÿ‡ธ USA